Iridex Expects 1Q Revenue to Be Flat to Slightly Higher

Dow Jones

Apr 15

By Katherine Hamilton

Iridex said it expects its first quarter revenue to be flat or slightly higher than the same period last year.

The maker of medical devices for eye diseases said Monday it anticipates revenue to be $11.8 million to $12 million for the quarter ended March 29, compared with $11.8 million in 2024.

Iridex said it was sharing preliminary results to highlight the stabilization of its business and improved financial condition.

Chief Executive Patrick Mercer said Iridex is exposed to external factors including tariff policies, but is still capable of achieving breakeven or better performance.

Preliminary results are based on initial analysis of operations.

Write to Katherine Hamilton at katherine.hamilton@wsj.com

(END) Dow Jones Newswires

April 14, 2025 16:29 ET (20:29 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2527141598"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2527141598\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2527141598?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-04-15 04:29","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2527141598","market":"hk","top_or_hot":-1,"title":"Iridex Expects 1Q Revenue to Be Flat to Slightly Higher","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Katherine Hamilton \n</p>\n<p>\n  Iridex said it expects its first quarter revenue to be flat or slightly higher than the same period last year. \n</p>\n<p>\n  The maker of medical devices for eye diseases said Monday it anticipates revenue to be $11.8 million to $12 million for the quarter ended March 29, compared with $11.8 million in 2024. \n</p>\n<p>\n  Iridex said it was sharing preliminary results to highlight the stabilization of its business and improved financial condition. \n</p>\n<p>\n  Chief Executive Patrick Mercer said Iridex is exposed to external factors including tariff policies, but is still capable of achieving breakeven or better performance. \n</p>\n<p>\n  Preliminary results are based on initial analysis of operations. \n</p>\n<p>\n  Write to Katherine Hamilton at katherine.hamilton@wsj.com \n</p>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  April 14, 2025 16:29 ET (20:29 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Iridex Expects 1Q Revenue to Be Flat to Slightly Higher</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIridex Expects 1Q Revenue to Be Flat to Slightly Higher\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-04-15 04:29</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Katherine Hamilton \n</p>\n<p>\n  Iridex said it expects its first quarter revenue to be flat or slightly higher than the same period last year. \n</p>\n<p>\n  The maker of medical devices for eye diseases said Monday it anticipates revenue to be $11.8 million to $12 million for the quarter ended March 29, compared with $11.8 million in 2024. \n</p>\n<p>\n  Iridex said it was sharing preliminary results to highlight the stabilization of its business and improved financial condition. \n</p>\n<p>\n  Chief Executive Patrick Mercer said Iridex is exposed to external factors including tariff policies, but is still capable of achieving breakeven or better performance. \n</p>\n<p>\n  Preliminary results are based on initial analysis of operations. \n</p>\n<p>\n  Write to Katherine Hamilton at katherine.hamilton@wsj.com \n</p>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  April 14, 2025 16:29 ET (20:29 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IRIX","symbol_name":"艾里德克斯","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2527141598","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2527141598","pubTimestamp":1744662540,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Iridex said it expects its first quarter revenue to be flat or slightly higher than the same period last year.The maker of medical devices for eye diseases said Monday it anticipates revenue to be $11.8 million to $12 million for the quarter ended March 29, compared with $11.8 million in 2024.Iridex said it was sharing preliminary results to highlight the stabilization of its business and improved financial condition.Chief Executive Patrick Mercer said Iridex is exposed to external factors including tariff policies, but is still capable of achieving breakeven or better performance.Preliminary results are based on initial analysis of operations.","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"IRIX":"艾里德克斯"},"translate_title":"Iridex预计第一季度收入将持平或略高","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IRIX":0.9},"content_text":"By Katherine Hamilton \n\n\n  Iridex said it expects its first quarter revenue to be flat or slightly higher than the same period last year. \n\n\n  The maker of medical devices for eye diseases said Monday it anticipates revenue to be $11.8 million to $12 million for the quarter ended March 29, compared with $11.8 million in 2024. \n\n\n  Iridex said it was sharing preliminary results to highlight the stabilization of its business and improved financial condition. \n\n\n  Chief Executive Patrick Mercer said Iridex is exposed to external factors including tariff policies, but is still capable of achieving breakeven or better performance. \n\n\n  Preliminary results are based on initial analysis of operations. \n\n\n  Write to Katherine Hamilton at katherine.hamilton@wsj.com \n\n\n  (END) Dow Jones Newswires\n\n\n  April 14, 2025 16:29 ET (20:29 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}